炔丙菊酯

炔烯菊酯(丙炔菊酯; 炔酮菊酯; 1RS,3SR)-2,2-二甲基-3-(2-甲基丙-1-烯基)环丙烷羧酸酯; 丙炔菊酯; 右旋丙炔菊酯; 益多克; (RS)-2-甲基-4-氧代-3-丙-2-炔基环戊-2-烯基(1RS，3RS; 炔丙菊酯; (1R)-2,2-二甲基-3-(2-甲基-1-丙烯基)环丙烷羧酸-(S)-2-甲基-3-(2-炔丙基)-4-氧代-环戊-2-烯基酯; 炔丙菊酯; (1R)-2,2-二甲基-3-(2-甲基-1-丙烯基)环丙烷羧酸-(S)-2-甲基-3-(2-炔丙基)-4-氧代-环戊-2-烯基酯

protopamiodide; 2-hydroxyiminomethyl-1-methylpyridinium iodide; (1Ξ)-2-methyl-4-oxo-3-(prop-2-yn-1-yl)cyclopent-2-en-1-yl (1Ξ,3Ξ)-2,2-dimethyl-3-(2-methylprop-1-en-1-yl)cyclopropane-1-carboxylate; 1-methyl-2-hydroxyiminomethylpyridinium iodide; pralidoximemethiodide; PRALIDOXIMELODIDE; 1RS,3SR)-2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate; PRALIDOXIME IODIDE; MFCD01632766; (RS)-2-methyl-4-oxo-3-prop-2-ynylcyclopent-2-enyl (1RS,3RS; pyridin-2-aldoxin; p-2-am; (RS)-2-methyl-4-oxo-3-prop-2-ynylcyclopent-2-enyl (1RS)-cis-trans-2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate; 2-PAM; 2-pamiodide; Prallethrin; (RS)-2-Methyl-4-oxo-3-prop-2-ynylcyclopent-2-enyl,1RS,3RS; 2-methyl-4-oxo-3-(2-propyn-1-yl)-2-cyclopenten-1-yl 2,2-dimethyl-3-(2-methyl-1-propen-1-yl)cyclopropanecarboxylate; EINECS 245-387-9; :(S)-2-Methyl-3-(2-propynyl)-4-oxocyclopent-2-enyl-(lR)-cis,trans-2,2-dimethyl-3-(2-methyl-1-propenyl)cyclopropanecarboxylate; 2-methyl-4-oxo-3-(prop-2-ynyl)cyclopent-2-en-1-yl 2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate; 2-methyl-4-oxo-3-(prop-2-yn-1-yl)cyclopent-2-en-1-yl (1S,3S)-2,2-dimethyl-3-(2-methylprop-1-en-1-yl)cyclopropanecarboxylate; 2-methyl-4-oxo-3-(prop-2-yn-1-yl)cyclopent-2-en-1-yl (1S,3R)-2,2-dimethyl-3-(2-methylprop-1-en-1-yl)cyclopropanecarboxylate; 2-methyl-4-oxo-3-prop-2-yn-1-ylcyclopent-2-en-1-yl 2,2-dimethyl-3-(2-methylprop-1-en-1-yl)cyclopropanecarboxylate; Prallethrin 92%TC

2-8°C

1、 摩尔折射率：84.78 2、 摩尔体积（cm3/mol）：277.1 3、 等张比容（90.2K）：696.4 4、 表面张力（dyne/cm）：39.8 5、 极化率（10-24cm3）：33.61

1.性状：原药为油状液体 2. 熔点（ºC）：>313.5 3.相对密度：1.03 4.溶解性：易溶于甲醇、己烷